30 september 2016
Inblick i samarbetet mellan Immunovia och Knight Cancer Institute, Oregon Portland USA, i den senaste Vatorpodden
I detta avsnitt av Vatorpodden, intervjuas Immunovias VD Mats Grahn och Dr Joseph Carroll, Senior Director of Business Development & Commercialization vid Knight Cancer Institute i Oregon, Portland, USA om den avgörande betydelsen av tidig diagnos av cancer.
Om Dr. Joseph Carroll
In his current role managing business development for the Knight Cancer Institute, Joseph helps to establish key alliances, partnerships and new ventures to help fulfill the Knight’s mission of ending cancer as we know it.
Joseph has a strong background in commercializing and translating genomic technologies in various disease settings. Over his 15 year career initiating and managing research efforts in biopharma and biotech (with companies such as Genetics Institute (acq. by Wyeth), Wyeth (acq. by Pfizer) and Millennium Pharmaceuticals), he has worked to utilize genomics to improve drug development and clinical trial design.